Chronic stressors produce changes in hippocampal neurochemistry, neuronal morphology, and hippocampal-dependent learning and memory processes. In rats, stress-induced changes in CA3 apical dendritic structure are mediated by corticosterone (CORT) acting, in part, on excitatory amino acid neurotransmission. CORT also alters GABA-mediated inhibitory neurotransmission, so the GABA A receptor system may also contribute to dendritic remodeling and other stress-related changes in hippocampal function. A previous study indicated that chronic CORT treatment produces complex changes in GABA A receptor subunit mRNA levels, so we hypothesized that CORT alters the pharmacological properties of hippocampal GABA A receptors. To test this, adult male rats were treated with CORT or vehicle pellets for 10 d, after which we quantified [ 
Repeated exposure to stressors produces neurochemical, synaptic, and morphological changes in the hippocampus, including selective regression of the apical dendrites in CA3 pyramidal neurons (Woolley et al., 1990; Magariños and McEwen, 1995; Magariños et al., 1996 Magariños et al., , 1998 and impaired performance in some spatial memory tasks (Luine et al., 1994; Conrad et al., 1996; Endo et al., 1996) . These stress effects are mediated, in part, by corticosteroids acting on excitatory amino acid neurotransmission (McEwen, 1999) . However, corticosterone (CORT) also modifies the actions of GABA, and GABA regulates hippocampal excitability (Freund and Buzsaki, 1996) and neurite extension (Mattson and Kater, 1989) . This suggests that chronic stressors may alter the balance between excitation and inhibition leading to dendritic remodeling and other changes in hippocampal function. Previous studies have shown that CORT alters GABA release and uptake (Miller et al., 1978; Ravindran et al., 1994) , radioligand binding to GABA A receptors (Goeders et al., 1986; Miller et al., 1988; Drugan et al., 1989; Weizman et al., 1990; Wilson and Biscardi, 1994) , and expression of GABA A receptor subunits (Kang et al., 1991; Orchinik et al., 1995) . In addition, benzodiazepines, positive allosteric modulators of GABA A receptors, can block stress-induced dendritic regression (Magariños et al., 1999) and the neurodegeneration produced by diminished expression of GABA A receptors (Karle et al., 1997) . However, these studies have not provided enough resolution to reveal how CORT and GABA interact to produce region-specific effects within the hippocampus.
The GABA A receptor is a pentamer, assembled from a diversity of subunits, that gates a chloride conductance (Nayeem et al., 1994; Hevers and Luddens, 1998; Mehta and Ticku, 1999 , and endogenous anxiolytic steroids such as 5␣-pregnane-3␣,21-diol-20-one (THDOC) (Majewska et al., 1986; Turner et al., 1989) . Native and recombinant GABA A receptors composed of different subunit combinations differ in pharmacological properties such as channel kinetics and allosteric modulation (Pritchett et al., 1989; Vicini, 1999) . Recent evidence is consistent with the idea that specific subunits are targeted to specific intracellular sites, producing functionally distinct receptor isoforms within the same neurons (Buhl et al., 1994; Koulen et al., 1996; Nusser et al., 1996; Ruano et al., 1997; Fritschy et al., 1998; Brickley et al., 1999; Banks and Pearce, 2000) .
A previous study found that chronic exposure to CORT produced site-and subunit-specific changes in the mRNA levels of Data collection. Receptor autoradiograms were analyzed by computerassisted densitometry (MCI D and AIS/C systems from Imaging Research, St. C atherines, Ontario, C anada). Optical density values in hippocampal regions of interest were quantified using an automated "paintbrush" f unction and converted to picomoles per gram of dry tissue using [
14 C] microscales ([ 35 S]TBPS binding) or to femtomoles per milligram of protein using [ 3 H] brain-mash standards (flunitrazepam binding). Mean values for each region were derived from sampling the left and right side of each section, two sections per slide, and 2 slides per animal. We used the following nomenclature conventions. We distinguished between the ectal (external) and endal (internal) limbs of the dentate gyrus and refer to them as the superior and inferior blades, respectively. We analyzed binding in the superior and inferior dendritic fields of the layer of polymorph cells that extends from the CA3 pyramidal cell layer between the blades of the dentate gyrus; these regions are referred to as CA4, strata radiatum, and strata oriens. Data from CA4 are reported in the Tables but were not included in statistical analyses because binding in this region was often quite diff use. In Ammon's horn, the area referred to as stratum radiatum may include some of the stratum lucidum.
Statistical anal ysis. We used a three-way nested, repeated-measures ANOVA model to test hypotheses about the equivalence of the treatment means (C ORT-treated vs vehicle-treated animals) and about the equivalence of the means at different dendritic subfields for each response variable ( DOC or GABA) . In the ANOVAs, the between group factor was the treatment (C ORT-treated vs vehicle-treated animals). The repeatedmeasure, hippocampal dendritic subfield was nested within a third factor, called hippocampal region, that had two levels: Ammon's horn and dentate gyrus. There were six dendritic subfields within Ammon's horn and two dendritic subfields within the dentate gyrus (molecular layers of inferior and superior blades). The normality assumption was investigated for all of the analyses by inspecting the normal plots of the residuals. In all cases, this inspection indicated that the errors were approximately normally distributed.
Rather than assuming a spherical covariance structure for the repeated measure (hippocampal dendritic subfield), which implies that the variances of the differences of the observations for all pairs of treatment levels are equivalent, we performed a maximum likelihood test for each variable to determine whether a more general covariance structure provided a superior fit. In each case, the maximum likelihood test indicated that the sphericity condition was too restrictive. Therefore, we modeled the relationships among the repeated measures (dendritic subfields) using an unstructured covariance matrix in all of the analyses.
When the interaction between treatment and dendritic subfield was significant (E xperiments 1 and 2), we performed hypothesis tests using contrasts (Set A) to determine whether C ORT treatment produced unique changes in CA3 stratum radiatum (where dendritic remodeling occurs) or the dentate gyrus (which provides excitatory input to CA3). The Set A contrasts tested the following: (1) the mean level of binding in CA3 stratum radiatum of C ORT-treated animals equals the mean level of binding in CA3 stratum radiatum of vehicle-treated animals, (2) the mean level of binding in the dentate gyrus of C ORT-treated animals equals the mean level of binding in the dentate gyrus of vehicle-treated animals, and (3) the difference between the mean level of binding in CA3 stratum radiatum of C ORT-treated animals minus the level in CA3 stratum radiatum of vehicle-treated animals equals the mean level of binding in CA1 stratum oriens of C ORT-treated animals minus the mean level in CA1 oriens of vehicle-treated animals. (4) This latter contrast was repeated for CA3 stratum radiatum versus CA1 stratum radiatum, (5) CA3 stratum radiatum versus CA2 stratum oriens, (6) CA3 stratum radiatum versus CA2 stratum radiatum, and (7) CA3 stratum radiatum versus CA3 stratum oriens. A family wise ␣ ϭ 0.05 significance level was used for all tests, and the Bonferroni method was used to control for simultaneous testing.
When the interaction between treatment and hippocampal region was significant (E xperiment 4), we performed two different hypothesis tests (Set B contrasts) that tested the following: (1) the mean level of binding in Ammon's horn of C ORT-treated animals equals the mean level of binding in Ammon's horn of vehicle-treated animals and (2) the mean level of binding in the dentate gyrus of C ORT-treated animals equals the mean level of binding in the dentate gyrus of vehicle-treated animals. In E xperiment 3, we performed an additional ANOVA to determine whether the means of the percentage modulation of CA3 strata radiatum, oriens, and pyramidale were equivalent.
The unexpected differences in the modulation of radioligand binding by TH DOC and GABA within Ammon's horn led us to develop exploratory hypothesis tests and construct additional contrasts (Set C) to examine binding in CA3 stratum radiatum relative to other dendritic subfields. When the main effect of dendritic subfield on the mean percentage modulation was significant, we performed Set C contrasts, which tested for the equivalence of (1) the mean percentage modulation in CA3 stratum radiatum and the mean percentage modulation in CA3 stratum oriens, (2) the mean percentage modulation in CA3 stratum radiatum and the mean percentage modulation in CA1 stratum radiatum, and (3) the mean percentage modulation CA3 stratum radiatum and the mean percentage modulation of CA1 oriens, CA1 radiatum, CA2 oriens, and CA2 radiatum. Again, a family wise ␣ ϭ 0.05 significance level and the Bonferroni method were applied. All statistical tests are summarized in Table 3 . (Fig. 1 ). In addition, GABA A receptors in CA3 stratum radiatum (apical dendritic region) appeared to differ pharmacologically from those in the stratum oriens (basal dendritic region). These results, detailed below, are consistent with our hypothesis.
RESULTS
There was no main effect of CORT treatment on the mean levels of basal [
35 S]TBPS binding, but there was a significant interaction between dendritic subfield and CORT treatment (F (6, 52) 35 S]TBPS binding in CORT-treated animals than in vehicle-treated animals. There were also differences between the mean levels of modulation by THDOC in Ammon's horn versus dentate gyrus (F (1,52) ϭ 1213; p Յ 0.0001) and between dendritic subfields within either Ammon's horn or the dentate gyrus, or both (F (6,52) ϭ 295.4; p Յ 0.0001).
The sensitivity of [ 35 S]TBPS binding to modulation by THDOC appeared to differ between the strata oriens and radiatum ( Fig. 1) , so we performed three exploratory hypothesis tests (Set C) on the data averaged over both treatment levels (see Table 3 ). These tests indicated that there were significant differences in the mean levels of percentage modulation of [
35 S]TBPS binding by THDOC between CA3 stratum radiatum and CA3 stratum oriens (t ϭ Ϫ34.65; p Յ 0.0001; THDOC inhibited a greater fraction of [
35 S]TBPS binding in CA3 stratum radiatum than stratum oriens), between CA3 stratum radiatum and CA1 stratum radiatum (t ϭ Ϫ9.95; p Յ 0.0001), and between CA3 stratum radiatum and the average of CA1 and CA2, stratum oriens and stratum radiatum (t ϭ 29.99; p Յ 0.0001). These data suggest that the pharmacological properties of GABA A receptors in CA3 radiatum differ from those in the stratum oriens of CA3 and from other regions of Ammon's horn. There was an overall significant main effect of CORT treatment on the mean percentage modulation by THDOC in hippocampus (F (1,52) ϭ 7.28; p ϭ 0.0094), indicated by an asterisk. There were also significant regional differences between mean levels of modulation by THDOC, averaged across treatments, between CA3 stratum radiatum and CA3 stratum oriens (t ϭ Ϫ34.65; p Յ 0.0001), and between CA3 stratum radiatum and CA1 stratum radiatum (t ϭ Ϫ9.95; p Յ 0.0001). See Table 3 for summary of statistical analysis.
cally relevant range, based on GABA EC 50 values (Costa, 1998) , and provided good modulatory contrasts. The results, detailed below, indicate that CORT treatment altered (probably decreased) the sensitivity of [
35 S]TBPS binding to modulation by GABA ( Fig. 3 ) and, again, that GABA A receptors in CA3 stratum radiatum appeared to differ from those in other regions of Ammon's horn.
As in Experiment 1, there was a significant interaction between dendritic subfield and CORT treatment on basal levels of [ 35 S]TBPS binding (F (6,16) ϭ 4.30; p ϭ 0.0091). However, as in Experiment 1, all of the Set A contrasts were nonsignificant. There were differences between the mean levels of basal binding in Ammon's horn and the dentate gyrus (F (1,16) ϭ 976.0; p Յ 0.0001) and between the mean levels of basal binding within the dendritic subfields in Ammon's horn, within the dentate gyrus, or within both (F (6,16) ϭ 212.4; p Յ 0.0001). At 1.5 M, GABA had dendritic region-specific effects on [ 35 S]TBPS binding. GABA enhanced [ 35 S]TBPS binding in the stratum oriens of CA1, CA2, and CA3 but inhibited binding or had no effect on binding in the stratum radiatum (Fig. 3) . Analysis of normalized data indicated that the mean percentage modulation of [
35 S]TBPS binding by GABA differed between CORT-and vehicle-treated animals ( Fig. 3) (F (1,16) ϭ 4.80; p ϭ 0.044); the percentage of basal binding was greater in CORTtreated animals. There were also significant differences between the mean level of modulation by GABA in Ammon's horn versus the mean level of modulation in dentate gyrus (F (1,16) ϭ 267.1; p Յ 0.0001), and between the means of the various dendritic subfields (F (6,16) ϭ 420.3; p Յ 0.0001).
The Set C contrasts (see Table 3 ) on normalized data averaged over both treatment levels indicated that there were significant differences in mean percentage modulation of [
35 S]TBPS binding by GABA between CA3 stratum radiatum and CA3 stratum oriens (t ϭ Ϫ13.56; p Յ 0.0001; GABA enhanced [ 35 S]TBPS binding in CA3 stratum oriens but not in stratum radiatum), between CA3 stratum radiatum and CA1 stratum radiatum (t ϭ 5.15; p Յ 0.0001), and between CA3 stratum radiatum and the average of CA1 and CA2, strata oriens, and radiatum (t ϭ 7.13; p Յ 0.0001). As with the modulation of [
35 S]TBPS binding by THDOC, these regional differences in the sensitivity to GABA indicate that the functional properties of GABA A receptors in CA3 stratum radiatum are likely to differ from those in the stratum oriens.
Experiment 3: Region-specific modulation of [ 35 S]TBPS binding by GABA
Experiment 2 revealed striking differences between the modulatory effect of GABA in the stratum radiatum versus stratum oriens (apical vs basal dendritic fields of pyramidal cells, respectively). Given this unexpected polarity, and the selective susceptibility of apical dendrites to stress-induced remodeling, we performed Experiment 3 to confirm that [ 35 S]TBPS binding is modulated in opposite directions by GABA in apical versus basal dendritic subfields. We further investigated the apparent heterogeneity of GABA A receptors in CA3 by examining binding in the pyramidal cell layer. The results, detailed below, confirmed that 1.5 M GABA enhanced [
35 S]TBPS binding in the stratum oriens of CA1, CA2, and CA3 but inhibited binding or had no effect on [
35 S]TBPS binding in the stratum radiatum. These data are consistent with the idea that hippocampal pyramidal neurons selectively sort GABA A receptor subtypes between the apical and basal dendrites.
As in Experiments 1 and 2, there was a significant interaction (F (6,16) ϭ 10.33; p Յ 0.0001) between hormone treatment and dendritic subfield on the basal levels of [
35 S]TBPS binding, and the Set A contrasts were again nonsignificant. Unlike Experiment 2, which used gonadally intact animals, there was no significant effect of CORT versus vehicle treatment on the mean percentage modulation by GABA; Experiment 3 used castrated animals. The focus of Experiment 3, however, was on regional differences in modulation of [
35 S]TBPS binding by GABA (Fig. 4 ). There were again differences between the mean percentage modulation by GABA in Ammon's horn versus the dentate gyrus (F (1,16) ϭ 127.6; p Յ 0.0001) and between the means of the individual dendritic subfields within either Ammon's horn or the dentate gyrus, or both (F (6,16) ϭ 278.0; p Յ 0.0001). As in Experiment 2, the Set C contrasts indicated that there were significant differences (see Table 3 ) in mean percentage modulation of [
35 S]TBPS binding by GABA between CA3 stratum radiatum and CA3 stratum oriens (t ϭ Ϫ17.82; p Յ 0.0001), between CA3 radiatum and CA1 stratum radiatum (t ϭ 8.40; p Յ 0.0001), and between CA3 stratum radiatum and the average of CA1 and CA2, stratum oriens, and stratum radiatum (t ϭ 9.46; p Յ 0.0001). Furthermore, we found that the mean percentage modulation of [
35 S]TBPS binding by GABA differed greatly between the strata oriens, radiatum, and pyramidale of CA3 (F (2,17) ϭ 229.0; p Յ 0.0001), ranging from 30% enhancement in stratum oriens to 40% inhibition in the pyramidal cell layer. There was a significant interaction between hippocampal region (Ammon's horn vs dentate gyrus) and CORT treatment on the mean levels of basal [ 3 H]flunitrazepam binding (F (1,16) ϭ 8.50; p ϭ 0.0101). Set B contrasts, however, indicated that basal binding was not significantly different between CORT-and vehicle-treated animals in either Ammon's horn or dentate gyrus. There were regional differences ( within either Ammon's horn or the dentate gyrus, or both (F (6,16) ϭ 202.7; p Յ 0.0001).
THDOC
Addition of 100 nM THDOC to the assay buffer (without exogenous GABA) produced a modest inhibition of [ 3 H]flunitrazepam binding in vehicle-treated animals ( Table 2 ). Analysis of normalized data (Fig. 5) (Table 2) . Analysis of normalized data (Fig. 6) (Table 3) ; there was a greater enhancement of [ 3 H]flunitrazepam binding by GABA in the dentate gyrus of CORT-treated animals relative to vehicle-treated controls. There were also significant regional differences in mean levels of modulation by GABA between Ammon's horn versus dentate gyrus (F (1,16) ϭ 28.57; p Յ 0.0001) and between dendritic subfields within either Ammon's horn or the dentate gyrus, or both (F (6,16) ϭ 2.79; p ϭ 0.0474). Exploratory hypothesis tests (Set C) indicated that there were no significant differences in the mean level of modulation of [ 3 H]flunitrazepam binding by GABA between the apical and basal dendritic subfields of Ammon's horn ( Table 3) .
Ratio of [ 35 S]TBPS to [ 3 H]flunitrazepam binding
We compared the ratio of chloride channel to benzodiazepine sites as another indicator of hippocampal GABA A receptor heterogeneity. Ratios were calculated from the total binding data in Experiments 2 and 4 in both CORT-and vehicle-treated animals.
These experiments used nonsaturating concentrations of [ 35 S]T-BPS and [
3 H]flunitrazepam in buffer with no exogenous GABA. There was a significant interaction between CORT treatment and dendritic subfields within either Ammon's horn or the dentate gyrus, or both (F (6,16) ϭ 7.06; p ϭ 0.0008) on the ratio means. However, Set A contrasts failed to detect a significant difference in ratio means between CORT-and vehicle-treated animals in CA3 stratum radiatum or dentate gyrus specifically. There were regional differences in the mean ratio of (1) The difference in ratios between Ammon's horn and dentate gyrus was significant (F (1,16) ϭ 10.33; p ϭ 0.0054), with a greater [
35 S]TBPS to [ 3 H]flunitrazepam ratio in the dentate gyrus than Ammon's horn, particularly compared with the stratum radiatum; (2) there were differences in ratio means in individual dendritic subfields within either Ammon's horn or the dentate gyrus, or both (F (6,16) ϭ 165.1; p Յ 0.0001). Additional hypothesis tests, performed for each level of treatment, indicated that the mean ratio of [
35 S]TBPS to [ 3 H]flunitrazepam binding was different (higher) in CA3 stratum oriens from CA3 stratum radiatum in both vehicle-treated (t ϭ Ϫ7.54; p Յ 0.0001) and CORT-treated (t ϭ Ϫ8.74; p Յ 0.0001) animals; different (higher) in CA3 stratum radiatum from CA1 radiatum in both vehicle-treated (t ϭ 15.47; p Յ 0.0001) and CORT-treated (t ϭ 14.47; p Յ 0.0001) animals; different in CA3 stratum radiatum from the average of CA1 and CA2, stratam oriens, and stratum radiatum means in both vehicle-treated (t ϭ Ϫ9.86; p Յ 0.0001) and CORT-treated (t ϭ Ϫ7.11; p Յ 0.0001) animals.
DISCUSSION
There were two major findings in this study. First, prolonged CORT treatment altered the sensitivity of GABA A receptors to modulation by GABA and THDOC. The altered sensitivity to endogenous modulators is consistent with a CORT-induced shift in the balance between excitatory and inhibitory neurotransmission. Second, there were marked intrahippocampal differences in the pharmacological properties of GABA A . These differences in radioligand binding are likely to represent differences in the receptor subtypes found in Ammon's horn relative to dentate gyrus and in the stratum radiatum relative to the stratum oriens within Ammon's horn. The latter suggests that GABA A receptor subtypes are selectively expressed in the apical versus basal dendrites within pyramidal neurons. 35 S]TBPS by GABA in Ammon's horn and dentate gyrus (F (1,16) ϭ 127.6; p Յ 0.0001) and between the means of the individual dendritic subfields (F (6,16) ϭ 278.0; p Յ 0.0001) in Ammon's horn or dentate gyrus, or both. Set C contrasts indicated significant differences, indicated by an asterisk, between the mean modulation of [
35 S]TBPS binding by GABA in CA3 stratum radiatum versus CA3 stratum oriens (t ϭ Ϫ17.82; p Յ 0.0001) and between CA3 stratum radiatum and CA1 stratum radiatum (t ϭ 8.40; p Յ 0.0001). Also note the striking differences in mean percentage modulation by GABA between layers I-III, IV, V, and VI of the parietal cortex.
To test our hypothesis that chronic exposure to stress levels of CORT alters pharmacological properties of hippocampal GABA A receptors, we examined the allosteric regulation of (Fig. 1) , suggesting a decrease in sensitivity to THDOC, and (2) (Hawkinson et al., 1994) . A decreased sensitivity of [
35 S]TBPS binding to modulation by THDOC and GABA would be consistent with a general increase in hippocampal excitability, whereas the increased sensitivity of [ 3 H]flunitrazepam binding to THDOC and GABA in the dentate gyrus suggests a localized increase in inhibitory tone. One hypothesis is that chronic CORT alters information flow through the hippocampus such that the massive excitatory input to CA3 from mossy fibers originating in the dentate gyrus is inhibited, whereas pyramidal cell responsiveness to excitatory input from entorhinal cortex, septum, or commissural fibers is enhanced. Stress-induced dendritic regression occurs in distal apical dendrites of CA3 that receive innervation from the entorhinal cortex, and, interestingly, lesions of the entorhinal cortex block this dendritic remodeling (Sunanda et al., 1997) .
CORT treatment had little effect on basal levels of [ 35 S]TBPS or [
3 H]flunitrazepam binding, so CORT effects on hippocampal circuits may be most apparent when THDOC levels are elevated, such as during stress (Paul and Purdy, 1992) . THDOC also has anxiolytic and anticonvulsant activity (Gasior et al., 1999) , in part mediated by the dorsal hippocampus (Bitran et al., 1999) . CORT treatment may decrease the efficacy or potency of THDOC as an anxiolytic in the hippocampus, and this may contribute to the anxiogenic actions of corticosteroids seen in some experimental paradigms (File et al., 1979; Smythe et al., 1997; Bitran et al., 1998; Conrad et al., 1999; Tronche et al., 1999) or contribute to the anxiety associated with major depression (Wong et al., 2000) . Consistent with this idea, fluoxetine, commonly used to treat mood disorders, increases the brain levels of 5␣-pregnan-3␣-ol-20-one (Uzunov et al., 1996) , a neurosteroid that modulates GABA A receptors in a manner very similar to THDOC. A similar mechanism may occur in prenatal stress, a condition that decreases the potency of 5␣-pregnan-3␣-ol-20-one as an anticonvulsant in adulthood (Frye and Bayon, 1999) . The conclusion that GABA A receptors in the stratum radiatum displayed different pharmacological properties relative to those in the stratum oriens is supported by the following. (1) (Buhl et al., 1994) , display unique physiological responses to GABA (Brickley et al., 1999; Banks and Pearce, 2000) , and stain for distinct GABA A receptor subunits (Nusser et al., 1996; Fritschy et al., 1998) .
There may be other explanations for regional differences in radioligand binding. First, modulation of [ 35 S]TBPS binding by THDOC is enhanced by GABA, so subcellular differences in sensitivity to THDOC may reflect regional differences in the abundance of GABA rather than receptor subtypes. However, we preincubated sections of tissues for 30 min before binding assays to minimize the contribution of endogenous GABA (Sapp et al., 1992) . Second, radioligand binding in the stratum oriens and stratum radiatum probably does not reflect binding to pyramidal cell receptors exclusively. GABAergic interneurons in Ammon's horn have extensive dendritic and axonal arbors in the stratum oriens and stratum radiatum (Buhl et al., 1994; Freund and Buzsaki, 1996) . These interneurons may be innervated by other GABAergic interneurons (Freund and Buzsaki, 1996) , and they express GABA A receptors (Gao and Fritschy, 1994; Sperk et al., 1997) . Therefore, some fraction of radioligand binding in the stratum oriens and stratum radiatum probably reflects binding to GABA A receptors in interneurons. Clearly, the functional outcomes would be quite different whether CORT altered the pharmacological properties of GABA A receptors in GABAergic interneurons rather than pyramidal cells, so it is important to determine the cellular targets for CORT action.
In addition to altering radioligand binding, chronic CORT treatment produced complex changes in GABA A receptor subunit mRNA levels (Orchinik et al., 1995) . The relative abundance of subunits may alter many properties of GABA A receptors and regulate the assembly, trafficking, or insertion of specific receptor Set A contrasts performed when the interaction between CORT versus VEH treatment and dendritic subfield was significant tested the equivalence of (1) the mean level of binding in CA3 stratum radiatum of CORT-treated animals and CA3 stratum radiatum of vehicle-treated animals, (2) the mean level of binding in the dentate gyrus of CORT-treated animals and dentate gyrus of vehicle-treated animals, (3) the difference between the mean level of binding in CA3 stratum radiatum of CORT-treated animals minus the level in CA3 stratum radiatum of vehicle-treated animals and the mean level of binding in CA1 stratum oriens of CORT-treated animals minus the mean level in CA1 oriens of vehicle-treated animals. (4) This latter contrast was repeated for CA3 stratum radiatum versus CA1 stratum radiatum, (5) CA3 stratum radiatum versus CA2 stratum oriens, (6) CA3 stratum radiatum versus CA2 stratum radiatum, (7) CA3 stratum radiatum versus CA3 stratum oriens. Set B contrasts performed when the interaction between CORT versus VEH treatment and hippocampal region was significant tested the equivalence of (1) the mean level of binding in Ammon's horn of CORT-treated animals and in Ammon's horn of vehicle-treated animals, (2) the mean level of binding in the dentate gyrus of CORT-treated animals and in dentate gyrus of vehicle-treated animals. Set C contrasts performed when there was a significant main effect of dendritic subfield on the mean percentage modulation tested the equivalence of (1) the mean percentage modulation in CA3 stratum radiatum and in CA3 stratum oriens, (2) the mean percentage modulation in CA3 stratum radiatum and in CA1 stratum radiatum, (3) the mean percentage modulation CA3 stratum radiatum and in CA1 oriens, CA1 radiatum, CA2 oriens, and CA2 radiatum. a Significance level set at a familywise ␣ ϭ 0.05; Bonferroni method was used to control for simultaneous testing; NS, nonsignificant; N/A, nonapplicable. b Additional repeated-measures ANOVA tested equivalence between the mean percentage modulation in CA3 strata radiatum, oriens, and pyramidale. 
